Agendia, Inc. seeks a board-certified MD/DO with AP or AP/CP to lead histopathology and molecular testing in a hybrid California role. You will interpret IHC, review QC, and sign-out genomic assays while collaborating with clinical and administrative staff to ensure quality and turnaround targets.
You will work closely with laboratory operations and engage in clinical studies, requiring strong communication and high attention to detail. CA license is required; NY license is a plus.
#J-18808-LjbffrMolecular Oncology Medical Director (Hybrid) in irvine at Unknown Company
This position is listed as full time and hybrid.